ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
5 things to watch on the ASX on Tuesday
Growth Shares
3 healthcare shares that could bring your portfolio to life
Growth Shares
3 top shares for growth investors
Healthcare Shares
Is it time to buy shares in CSL Limited (ASX:CSL)?
Growth Shares
Why I rate ResMed Inc (ASX:RMD) as one of the ASX's best growth shares
⏸️ ASX Shares
Should you buy these healthcare shares?
Share Market News
Is CSL Limited's (ASX:CSL) share price at risk of tumbling next week?
Share Market News
Leading brokers name 3 ASX shares to buy
Share Market News
Earnings season week two preview
Share Market News
ALL ORDINARIES finishes lower Friday: 9 shares you missed
Share Market News
Why this fund manager thinks the market is underappreciating ResMed Inc (ASX:RMD)
Share Market News
How ResMed Inc (ASX:RMD) just delivered more strong profit growth
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
